Atlas Trials

Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin

Clinical trial NCT01990469 · COMPLETED

Trial details

NCT number
NCT01990469
Sponsor
LG Life Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
T2DM
Start date
2014-01-01
Primary completion
2015-04-01
Enrollment
219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.